分子诊断和个性化治疗肝细胞癌的新兴作用

Ming-Da Wang1, Yong-Kang Diao1, Lan-Qing Yao1

  • 1Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Navy Medical University), Shanghai 200438, China.

ILIVER..
|July 10, 2025
PubMed
概括

肝细胞癌 (HCC) 研究推动了分子诊断和个性化治疗. 下一代测序和液体活检改善了早期检测,治疗选择和监测,以获得更好的患者结果.